<?xml version="1.0" encoding="UTF-8"?>
<p id="Par85">The development of small molecule inhibitors targeted at writers, erasers and readers in m6A modification process is expected to improve antiviral therapy. Recent studies have shown that the use of writer inhibitors may affect viral replication and the development of tumors [
 <xref ref-type="bibr" rid="CR1">1</xref>, 
 <xref ref-type="bibr" rid="CR47">47</xref>, 
 <xref ref-type="bibr" rid="CR84">84</xref>]. Thus, inhibition of m6A modification may be a potential therapy for virus induced diseases.
</p>
